153 related articles for article (PubMed ID: 9534679)
1. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting.
Yoshikawa T; Suga S; Kozawa T; Kawaguchi S; Asano Y
Arch Dis Child; 1998 Jan; 78(1):61-3. PubMed ID: 9534679
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
3. Comparison of specific immunities to varicella-zoster virus following post-exposure prophylaxis of varicella by oral acyclovir observed in a family.
Asano Y; Suga S; Yoshikawa T
Acta Paediatr Jpn; 1996 Dec; 38(6):692-4. PubMed ID: 9002312
[TBL] [Abstract][Full Text] [Related]
4. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
5. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.
Ogilvie MM
J Infect; 1998 Jan; 36 Suppl 1():31-8. PubMed ID: 9514106
[TBL] [Abstract][Full Text] [Related]
6. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
Bate J; Baker S; Breuer J; Chisholm JC; Gray J; Hambleton S; Houlton A; Jit M; Lowis S; Makin G; O'Sullivan C; Patel SR; Phillips R; Ransinghe N; Ramsay ME; Skinner R; Wheatley K; Heath PT
Arch Dis Child; 2019 Jan; 104(1):25-29. PubMed ID: 29730641
[TBL] [Abstract][Full Text] [Related]
7. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir prophylaxis of varicella after household exposure.
Huang YC; Lin TY; Chiu CH
Pediatr Infect Dis J; 1995 Feb; 14(2):152-4. PubMed ID: 7746701
[No Abstract] [Full Text] [Related]
9. Oral acyclovir prophylaxis of varicella after intimate contact.
Lin TY; Huang YC; Ning HC; Hsueh C
Pediatr Infect Dis J; 1997 Dec; 16(12):1162-5. PubMed ID: 9427463
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
11. Postexposure prophylaxis of varicella in family contact by oral acyclovir.
Asano Y; Yoshikawa T; Suga S; Kobayashi I; Nakashima T; Yazaki T; Ozaki T; Yamada A; Imanishi J
Pediatrics; 1993 Aug; 92(2):219-22. PubMed ID: 8393173
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children.
Englund JA; Arvin AM; Balfour HH
J Clin Microbiol; 1990 Oct; 28(10):2327-30. PubMed ID: 2172288
[TBL] [Abstract][Full Text] [Related]
14. Varicella zoster exposure on paediatric wards between 2000 and 2007: safe and effective post-exposure prophylaxis with oral aciclovir.
Shinjoh M; Takahashi T
J Hosp Infect; 2009 Jun; 72(2):163-8. PubMed ID: 19282055
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of oral aciclovir in preventing maternal chickenpox: A comparison with VZIG.
Sile B; Brown KE; Gower C; Bosowski J; Dennis A; Falconer M; Stowe J; Andrews N; Amirthalingam G
J Infect; 2022 Aug; 85(2):147-151. PubMed ID: 35659543
[TBL] [Abstract][Full Text] [Related]
17. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
18. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
[TBL] [Abstract][Full Text] [Related]
20. [Summary of the multidisciplinary guideline 'Varicella'].
Rothbarth PH; Hartwig NG; Opstelten W
Ned Tijdschr Geneeskd; 2011; 155(51):A3511. PubMed ID: 22200141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
